The Second Battle, Opened From the Inside
The Second Battle, Opened From the Inside Octreotide, acromegaly and the tight-junction trick that takes on the gut wall directly Rybelsus proved […]
Read moreTag: bioavailability
Who Decided How Big a Tablet Should Be?
The hidden engineering behind every pill you’ve ever taken The size of a tablet feels like a design decision. It isn’t. It […]
Read moreNaproxen: A Case Study in Conservative Formulation
When a superior molecule is held back by its delivery system Naproxen’s long-lasting effect is well known. Its slow start is the […]
Read moreThe End of the Tablet Era
The best-selling drug in the world is no longer a tablet. The pipeline behind it is no longer led by small molecules. […]
Read moreBeyond Dissolution: Reframing Lipid Functionality
Why the next chapter in oral drug delivery is being written by lipids — and not the ones you think. Lipid-based delivery […]
Read morePharma Optimised for Factories, Not Humans
The compressed tablet was a 19th-century manufacturing fix. It became the unquestioned default of modern medicine. Modern medicine can design a molecule […]
Read moreWhy Are Pills Round?
The shape of the most-produced manufactured object in human history was decided in 1843. The patient was never in the room. The […]
Read moreThe 80% Problem
Why the most consequential number in pharma is the one nobody says out loud Ninety-nine of every hundred milligrams in the most […]
Read more
Bioavailability Is Pharma’s Dirty Secret
The Illusion of Effectiveness The single number that decides whether a medicine works. The one number patients are never told. (7-minute read) […]
Read moreAI Designed the Molecule. It Still Failed the Patient.
Drug Delivery as the Missing Layer in the AI-Enabled Pharmaceutical Stack Abstract Artificial intelligence (AI) is reshaping pharmaceutical research by accelerating target […]
Read more